Skip to main content

Galectin Therapeutics Inc

GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001133416

In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Galectin Therapeutics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of GALT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders75750
Shares9.94M7.92M−2.02M (−20.3%)
Value$22.7M$25.3M+$2.60M (+11.4%)

New holders (20)

Institutions that held Galectin Therapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to GALT in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC568,690$1.82M0.00%
Cambridge Investment Research Advisors, Inc.168,316$539.0K0.00%
Ergoteles LLC139,181$445.0K0.01%
HRT Financial LP104,946$335.0K0.00%
Tibra Equities Europe Ltd98,700$316.0K0.10%
Squarepoint Ops LLC56,128$180.0K0.00%
Marshall Wace, LLP47,509$152.0K0.00%
ExodusPoint Capital Management, LP42,042$135.0K0.00%
Ameritas Investment Company, LLC39,232$126.0K0.01%
Qci Asset Management Inc25,000$80.0K0.00%
Horizon Kinetics Asset Management LLC24,000$77.0K0.00%
LMR Partners LLP19,285$62.0K0.00%
Susquehanna Fundamental Investments, LLC15,600$50.0K0.00%
XTX Topco Ltd12,419$40.0K0.01%
Jane Street Group, LLC11,133$36.0K0.00%
Boothbay Fund Management, LLC10,965$35.0K0.00%
Pinz Capital Management, LP6,300$20.0K0.01%
O'Shaughnessy Asset Management, LLC5,655$18.0K0.00%
Meeder Asset Management Inc4,917$16.0K0.00%
Captrust Financial Advisors213$1.00K0.00%

Sold out (20)

Institutions that held Galectin Therapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.